Le Lézard
Classified in: Health, Business
Subject: OFR

HumanCo Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing January 28, 2021


AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ -- HumanCo Acquisition Corp. (NASDAQ: HMCOU) (the "Company") announced that, commencing January 28, 2021, holders of the units sold in the Company's initial public offering of 28,750,000 units may elect to separately trade the shares of Class A common stock and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "HMCOU," and the shares of Class A common stock and redeemable warrants that are separated will trade on Nasdaq under the symbols "HMCO" and "HMCOW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and redeemable warrants.

The units were initially offered by the Company in an underwritten offering. Citigroup Global Markets Inc. acted as sole book-running manager.  A registration statement relating to the units and the underlying securities became effective on December 8, 2020.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering was made only by means of a prospectus, copies of which may be obtained for free from the Securities and Exchange Commission (the "SEC") website at www.sec.gov or by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-800-831-9146.

About HumanCo Acquisition Corp.

HumanCo Acquisition Corp. is a blank check company incorporated as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus on the industries that complement the management team's background, and to capitalize on their demonstrated ability to identify and acquire businesses focusing on Health and Wellness and related industries in the United States. For more information about HumanCo Acquisition Corp., please visit www.humancospac.com.

Forward-Looking Statements

This press release may include "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including with respect to the anticipated separate trading of the Company's Class A common stock and redeemable warrants and the pursuit of an initial business combination. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus relating to the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

Amy Zipper
Chief Operating Officer
amy@humanco.com

SOURCE HumanCo Acquisition Corp.


These press releases may also interest you

at 13:56
The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks. Through the Wellness Together Canada online portal, people of all ages across the...

at 13:00
Flip the Pharmacy, a 5-year pharmacy transformation program directly supporting over 800 community-based pharmacies and impacting thousands more, announced the winners of its inaugural Flip the Pharmacy Awards. The year one winners are: Pharmacy of...

at 12:30
Earlier today, Safe & Sound Treatment, a drug and alcohol rehabilitation facility in California, announced it will be offering medically assisted detox for drugs and alcohol in Costa Mesa. The rehab center plans to ease the transition for addicts...

at 11:00
The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show: 1,537 new cases, bringing the total number of people infected to 335,608; 311,047 people have recovered; 8 new deaths, for a total of 10,793 deaths: 5 deaths in...

at 09:55
Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the...

at 09:00
Half of the children who developed the serious condition associated with COVID-19 called multisystem inflammatory syndrome in children (MIS-C) had neurologic symptoms or signs when they entered the hospital, according to preliminary research that...



News published on 27 january 2021 at 16:01 and distributed by: